Voices
Guidelines to Mitigate Cancer Therapy-Related Cardiac Dysfunction – ICOS
International Cardio-Oncology Society/lgcw.org.uk

Guidelines to Mitigate Cancer Therapy-Related Cardiac Dysfunction – ICOS

International Cardio-Oncology Society(ICOS) shared a post on LinkedIn:

“Breaking News

We are proud to announce our new consensus statement, outlining how hematology and oncology can consistently apply cardio-oncology guidelines to mitigate Cancer therapy-related cardiac dysfunction (CTRCD).”

Title: Standardizing the Clinical Approach to Cancer Therapy-Related Cardiac Dysfunction: Applying Cardio-Oncology Guidelines as a Practical Tool for Hematology and Oncology Providers

Authors: Abdelrahman Ali, Suparna C. Clasen, Anne Blaes, Stephen Casselli, Anita Deswal, Susan Halli Demeter, Gregory Durm, Anecita Fadol, Alessandra Ferrajoli, Michael G. Fradley, Joerg Herrmann, Borja Ibanez, Sue Koob, Bogda Koczwara, Kasey J. Leger, Jennifer E. Liu, Teresa López-Fernández, Alexander R. Lyon, N. G. Choon Ta, John Teerlink, Eric H. Yang, Susan Dent, Daniel Lenihan

Read The Full article

Guidelines to Mitigate Cancer Therapy-Related Cardiac Dysfunction - ICOS

Other articles about International Cardio-Oncology Society on OncoDaily.

Abdelrahman Ali Alessandra Ferrajoli Alexander R. Lyon Anecita Fadol Anita Deswal Anne Blaes Bogda Koczwara Borja Ibáñez cancer Daniel Lenihan Eric H Yang Gregory Durm ICOS International Cardio-Oncology Society Jennifer E. Liu Joerg Herrmann John Teerlink Kasey J. Leger Michael G. Fradley N. G. Choon Ta OncoDaily Oncology Stephen Casselli Sue Koob Suparna C. Clasen Susan Dent Susan Halli Demeter Teresa López Fernández